Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement. GAO-01-754. Washington, DC, 2001. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-754
Government Accountability Office. (2001, July 6). GAO-01-754 - Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-754
Government Accountability Office. GAO-01-754 - Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement. U.S. Government Printing Office, (6 Jul 2001), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-754
Government Accountability Office, Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement, GovInfo, (July 6, 2001), https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-754